Genetic susceptibility to neurodevelopmental disorders

Modeling neurodevelopmental disorders using human pluripotent stem cells

Neurodevelopmental disorders (NDs) are impairments that affect the development and growth of the brain and the central nervous system during embryonic and early postnatal life. Genetically manipulated animals have contributed greatly to the advancement of ND research, but many of them differ considerably from the human phenotype. Cellular in vitro models are also valuable, but the availability of human neuronal cells is limited and their lifespan in culture is short. Human pluripotent stem cells (hPSCs), including embryonic stem cells and induced pluripotent stem cells, comprise a powerful tool for studying developmentally regulated diseases, including NDs. We reviewed all recent studies in which hPSCs were used as in vitro models for diseases and syndromes characterized by impairment of neurogenesis or synaptogenesis leading to intellectual disability and delayed neurodevelopment. We analyzed their methodology and results, focusing on the data obtained following in vitro neural differentiation and gene expression and profiling of the derived neurons. Electrophysiological recording of action potentials, synaptic currents and response to neurotransmitters is pivotal for validation of the neuronal fate as well as for assessing phenotypic dysfunctions linked to the disease in question. We therefore focused on the studies which included electrophysiological recordings on the in vitro-derived neurons. Finally, we addressed specific issues that are critical for the advancement of this area of research, specifically in providing a reliable human pre-clinical research model and drug screening platform.

Childhood autism and associated comorbidities

Autism is a heterogeneous neurodevelopmental disorder with a variety of different etiologies, but with a heritability estimate of more than 90%. Although the strong correlation between autism and genetic factors has been long established, the exact genetic background of autism is still unclear. This review refers to all the genetic syndromes that have been described in children with pervasive developmental disorders (tuberous sclerosis, fragile X, Down, neurofibromatosis, Angelman, Prader-Willi, Gilles de la Tourette, Williams, etc.). Issues covered include prevalence and main characteristics of each syndrome, as well as the possible base of its association with autism in terms of contribution to the current knowledge on the etiology and genetic base of pervasive developmental disorders.

Specific reading disability: a multiplanar view

In the past three decades a revolution has altered the way society approaches people with disabilities. Social changes resulted in a significant increase in fundamental and applied research that seeks to improve the lives of people with disabilities by facilitating better understanding of the mechanisms, manifestations, prevention, and treatment of functional impairment. Specific Reading Disability (SRD) has benefited from this revolution. This review focuses on the evolution of SRD, new information in its neurobiology and management, and the challenges that remain. Evidence from a wide spectrum of research provides strong support for the role of phonology in Specific Reading Disability. Despite the mounting evidence, the case is far from completely established. Adults with compensated SRD read but still demonstrate disordered phonology (Felton et al. [1990] Brain Language 39:485-497). Whether poor phonology is causal or a covariant remains to be demonstrated. Of children with poor phonology, it is not known how many are poor readers. While phonology is associated with SRD, other studies have questioned the uniqueness of SRD. Challenges have been made to the method of classification, the uniqueness of phonological dysfunction as a mechanism in SRD and the response to treatment. In the final analysis all poor readers may have a common core of dysphonology, independent of whether their reading is discrepant from their IQ.

Epidemiology of neurodevelopmental disorders in children

The epidemiology of mental and behavioural disorders is considered in comparison with spina bifida, chromosomal anomalies and brain tumours. Descriptive epidemiology is important not only in assessing the frequency of neurodevelopmental disorders, thereby aiding planning of service provision, but also because variations by geographical area, over time, and by personal characteristics provide clues regarding etiology. The value of the latter application is exemplified by research on spina bifida and other neural tube defects (NTDs). The descriptive epidemiology of mental and behavioural disorders has been less investigated. The descriptive epidemiology of NTDs suggested that diet might be of etiological importance. Analytical epidemiologic investigation proceeded by testing dietary hypotheses in case-control and cohort studies. Subsequently, folate supplementation was shown to reduce recurrence risk in a randomized controlled trial. The analytical epidemiology of other neurodevelopmental disorders is less well understood. Study design issues are discussed in relation to mental and behavioural disorders.